Oxford Nanopore Technologies Plc (ONTTF)
2.05
-0.12
(-5.53%)
USD |
OTCM |
Sep 10, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.999B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -15.98% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 6.285 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Oxford Nanopore Technologies Plc develops proprietary technology platform for the electronic analysis of single molecules. The firm also develops instruments like GridIONTM and MinIONTM which are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. Its platform has a broad range of potential applications, including scientific research, personalized medicine, crop science and security and defense. The company was founded by Gordon Sanghera, Spike Willcocks and John Hagan Pryce Bayley in 2005 and is headquartered in Oxford, the United Kingdom. |
| URL | http://nanoporetech.com |
| Investor Relations URL | N/A |
| HQ State/Province | Oxfordshire |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Core |
| Next Earnings Release | Mar. 03, 2027 (est.) |
| Last Earnings Release | Aug. 19, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Oxford Nanopore Technologies Plc develops proprietary technology platform for the electronic analysis of single molecules. The firm also develops instruments like GridIONTM and MinIONTM which are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. Its platform has a broad range of potential applications, including scientific research, personalized medicine, crop science and security and defense. The company was founded by Gordon Sanghera, Spike Willcocks and John Hagan Pryce Bayley in 2005 and is headquartered in Oxford, the United Kingdom. |
| URL | http://nanoporetech.com |
| Investor Relations URL | N/A |
| HQ State/Province | Oxfordshire |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Core |
| Next Earnings Release | Mar. 03, 2027 (est.) |
| Last Earnings Release | Aug. 19, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |